• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于早产儿的呼吸触发式药物释放系统。

Breath-Triggered Drug Release System for Preterm Neonates.

作者信息

Wiegandt Felix C, Froriep Ulrich P, Müller Fabian, Doll Theodor, Dietzel Andreas, Pohlmann Gerhard

机构信息

Division of Translational Biomedical Engineering, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, 30625 Hannover, Germany.

Department of Otorhinolaryngology, Hannover Medical School, 30625 Hannover, Germany.

出版信息

Pharmaceutics. 2021 May 4;13(5):657. doi: 10.3390/pharmaceutics13050657.

DOI:10.3390/pharmaceutics13050657
PMID:34064425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8147847/
Abstract

A major disadvantage of inhalation therapy with continuous drug delivery is the loss of medication during expiration. Developing a breath-triggered drug release system can highly decrease this loss. However, there is currently no breath-triggered drug release directly inside the patient interface (nasal prong) for preterm neonates available due to their high breathing frequency, short inspiration time and low tidal volume. Therefore, a nasal prong with an integrated valve releasing aerosol directly inside the patient interface increasing inhaled aerosol efficiency is desirable. We integrated a miniaturized aerosol valve into a nasal prong, controlled by a double-stroke cylinder. Breathing was simulated using a test lung for preterm neonates on CPAP respiratory support. The inhalation flow served as a trigger signal for the valve, releasing humidified surfactant. Particle detection was performed gravimetrically (filter) and optically (light extinction). The integrated miniaturized aerosol valve enabled breath-triggered drug release inside the patient interface with an aerosol valve response time of <25 ms. By breath-triggered release of the pharmaceutical aerosol as a bolus during inhalation, the inhaled aerosol efficiency was increased by a factor of >4 compared to non-triggered release. This novel nasal prong with integrated valve allows breath-triggered drug release directly inside the nasal prong with short response time.

摘要

持续给药的吸入疗法的一个主要缺点是呼气时药物损失。开发一种呼吸触发式药物释放系统可以大幅减少这种损失。然而,由于早产儿呼吸频率高、吸气时间短和潮气量低,目前尚无直接在患者接口(鼻叉)内实现呼吸触发式药物释放的产品。因此,需要一种在患者接口内直接释放气溶胶的集成阀门的鼻叉,以提高吸入气溶胶的效率。我们将一个小型化的气溶胶阀集成到一个鼻叉中,由一个双冲程气缸控制。使用用于接受持续气道正压通气(CPAP)呼吸支持的早产儿的测试肺模拟呼吸。吸入气流用作阀门的触发信号,释放加湿的表面活性剂。通过重量法(过滤器)和光学法(光消光)进行颗粒检测。集成的小型化气溶胶阀能够在患者接口内实现呼吸触发式药物释放,气溶胶阀响应时间<25毫秒。通过在吸气期间以团注形式呼吸触发式释放药物气溶胶,与非触发式释放相比,吸入气溶胶效率提高了>4倍。这种带有集成阀门的新型鼻叉允许在鼻叉内直接进行呼吸触发式药物释放,响应时间短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/f652d83e0472/pharmaceutics-13-00657-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/99e6a2c9329b/pharmaceutics-13-00657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/155b2d295032/pharmaceutics-13-00657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/015c220a06bf/pharmaceutics-13-00657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/4eaf2d132d10/pharmaceutics-13-00657-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/b57cdf37cb06/pharmaceutics-13-00657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/0d5ec653291b/pharmaceutics-13-00657-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/f652d83e0472/pharmaceutics-13-00657-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/99e6a2c9329b/pharmaceutics-13-00657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/155b2d295032/pharmaceutics-13-00657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/015c220a06bf/pharmaceutics-13-00657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/4eaf2d132d10/pharmaceutics-13-00657-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/b57cdf37cb06/pharmaceutics-13-00657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/0d5ec653291b/pharmaceutics-13-00657-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/8147847/f652d83e0472/pharmaceutics-13-00657-g007.jpg

相似文献

1
Breath-Triggered Drug Release System for Preterm Neonates.用于早产儿的呼吸触发式药物释放系统。
Pharmaceutics. 2021 May 4;13(5):657. doi: 10.3390/pharmaceutics13050657.
2
Novel Test Bench for Inhaler Characterization Including Real-Time Determination of Output, Output Rate, and Liquid Water Content of Delivered Aerosols.一种新型吸入器特性测试台,可实时测定气雾剂输出量、输出速率和输送液滴的含水量。
J Aerosol Med Pulm Drug Deliv. 2021 Feb;34(1):32-41. doi: 10.1089/jamp.2020.1611. Epub 2020 Jul 22.
3
Wet-Side Breath-Enhanced Jet Nebulization: Controlling Drug Delivery During Mechanical Ventilation.湿化端增强射流雾化:机械通气中药物输送的控制。
Respir Care. 2020 Aug;65(8):1077-1089. doi: 10.4187/respcare.07343. Epub 2020 Mar 24.
4
Detection of Breathing Movements of Preterm Neonates by Recording Their Abdominal Movements with a Time-of-Flight Camera.使用飞行时间相机记录早产新生儿的腹部运动以检测其呼吸运动
Pharmaceutics. 2021 May 14;13(5):721. doi: 10.3390/pharmaceutics13050721.
5
Comparison of HFNC, bubble CPAP and SiPAP on aerosol delivery in neonates: An in-vitro study.高流量鼻导管吸氧、气泡式持续气道正压通气和同步间歇指令通气用于新生儿气溶胶输送的比较:一项体外研究
Pediatr Pulmonol. 2015 Nov;50(11):1099-106. doi: 10.1002/ppul.23123. Epub 2014 Dec 9.
6
A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.一种新型连续粉末雾化器(CPA),用于对早产儿吸入给予高浓度重组表面活性蛋白-C(rSP-C)表面活性剂。
J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):370-9. doi: 10.1089/jamp.2012.0996. Epub 2013 Feb 19.
7
In vitro evaluation of radio-labeled aerosol delivery via a variable-flow infant CPAP system.通过可变流量婴儿 CPAP 系统进行放射性标记气溶胶输送的体外评估。
Respir Care. 2014 Mar;59(3):340-4. doi: 10.4187/respcare.01904. Epub 2013 Aug 6.
8
From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.从实验室到病床:新生儿聚焦型雾化表面活性剂递送策略的体外与体内评价。
Respir Res. 2019 Jul 2;20(1):134. doi: 10.1186/s12931-019-1096-9.
9
Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.用于早产儿鼻持续气道正压通气(NCPAP)的设备和压力源。
Cochrane Database Syst Rev. 2002(4):CD002977. doi: 10.1002/14651858.CD002977.
10
In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy.高流量鼻腔治疗期间呼吸模式对气溶胶输送影响的体外研究
Pulm Ther. 2019 Jun;5(1):43-54. doi: 10.1007/s41030-019-0086-x. Epub 2019 Feb 6.

引用本文的文献

1
Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.肺表面活性物质雾化给药联合经鼻持续气道正压通气治疗新生儿呼吸窘迫综合征
Front Pediatr. 2022 Jun 15;10:923010. doi: 10.3389/fped.2022.923010. eCollection 2022.
2
Detection of Breathing Movements of Preterm Neonates by Recording Their Abdominal Movements with a Time-of-Flight Camera.使用飞行时间相机记录早产新生儿的腹部运动以检测其呼吸运动
Pharmaceutics. 2021 May 14;13(5):721. doi: 10.3390/pharmaceutics13050721.

本文引用的文献

1
Detection of Breathing Movements of Preterm Neonates by Recording Their Abdominal Movements with a Time-of-Flight Camera.使用飞行时间相机记录早产新生儿的腹部运动以检测其呼吸运动
Pharmaceutics. 2021 May 14;13(5):721. doi: 10.3390/pharmaceutics13050721.
2
Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.雾化药物递送至自主呼吸的早产儿:经验教训。
Respir Res. 2021 Feb 26;22(1):71. doi: 10.1186/s12931-020-01585-9.
3
Regional Deposition: Targeting.区域性沉积:靶向治疗。
J Aerosol Med Pulm Drug Deliv. 2021 Feb;34(1):1-10. doi: 10.1089/jamp.2021.29033.am. Epub 2020 Dec 15.
4
Novel Test Bench for Inhaler Characterization Including Real-Time Determination of Output, Output Rate, and Liquid Water Content of Delivered Aerosols.一种新型吸入器特性测试台,可实时测定气雾剂输出量、输出速率和输送液滴的含水量。
J Aerosol Med Pulm Drug Deliv. 2021 Feb;34(1):32-41. doi: 10.1089/jamp.2020.1611. Epub 2020 Jul 22.
5
Contact-Based Methods for Measuring Respiratory Rate.基于接触的呼吸频率测量方法。
Sensors (Basel). 2019 Feb 21;19(4):908. doi: 10.3390/s19040908.
6
Underdosing of Surfactant for Preterm Babies with Respiratory Distress Syndrome in Clinical Practice: A Retrospective Cohort Study.临床实践中表面活性物质治疗呼吸窘迫综合征早产儿的低剂量用药:一项回顾性队列研究。
Am J Perinatol. 2019 Jul;36(9):943-948. doi: 10.1055/s-0038-1675645. Epub 2018 Nov 10.
7
In Vitro Comparison of a Vibrating Mesh Nebulizer Operating in Inspiratory Synchronized and Continuous Nebulization Modes During Noninvasive Ventilation.无创通气期间振动筛孔雾化器在吸气同步和持续雾化模式下的体外比较
J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):328-36. doi: 10.1089/jamp.2015.1243. Epub 2016 Jun 16.
8
Nasal intermittent positive pressure ventilation in preterm infants: Equipment, evidence, and synchronization.早产儿的经鼻间歇正压通气:设备、证据与同步性
Semin Fetal Neonatal Med. 2016 Jun;21(3):146-53. doi: 10.1016/j.siny.2016.01.003. Epub 2016 Feb 26.
9
Surfactant replacement therapy for preterm and term neonates with respiratory distress.表面活性物质替代疗法治疗有呼吸窘迫的早产儿和足月儿。
Pediatrics. 2014 Jan;133(1):156-63. doi: 10.1542/peds.2013-3443. Epub 2013 Dec 30.
10
Optimal delivery of aerosols to infants during mechanical ventilation.机械通气时向婴儿输送气雾剂的最佳方法。
J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):371-85. doi: 10.1089/jamp.2013.1077. Epub 2013 Dec 3.